$CME

CME Plans World's First Tungsten Futures As Booming Missile Demand May Spark Severe 2030 Shortage

CME Group plans to launch the world's first tungsten futures contract in early 2027, aiming to provide price transparency and hedging opportunities. The contract will be settled against Fastmarkets' Western benchmark for ammonium paratungstate (APT). Almonty Industries, a tungsten producer, presented its operating outlook and expansion projects, highlighting its role in supplying conflict-free tungsten to Western markets.

Original reporting
Published Oct 20, 2026, 7:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 10:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CME Plans World's First Tungsten Futures As Booming Missile Demand May Spark Severe 2030 Shortage — source image
Decision brief

The 30-second read

$CMENeutralMed
01

Why it matters

The futures launch creates a new hedging tool, potentially stabilizing prices and supporting miners like Almonty.

02

Market read

The announcement adds a first‑of‑its‑kind instrument for a strategic metal, with implications for commodity markets and mining equities.

03

What to watch

Regulatory approval timelines and potential restrictions on tungsten trading could delay launch and dampen market enthusiasm.

Relevance 7/10Novelty 7/10Timing: announcement today, trading to start early 1Q27

Background

CME Group is expanding its suite of critical‑metal contracts amid rising geopolitical tension and supply constraints for tungsten.

Company-level read

Ticker impact

$CMENeutralHigh confidence
Context

CME Group announced plans to launch the first tungsten futures contract, a new market instrument for the critical metal.

Expected impact

likely modest upside for CME as the product adds fee revenue, but no immediate price move.

Evidence & confidence

CME's launch is a primary disclosure; the market will price in the new offering over the next months.

Market effects

Introduces a tradable benchmark for tungsten, potentially spurring more investment in critical‑metal mining and processing firms.

May benefit Western producers and reduce reliance on Chinese supply, especially in Europe and North America.

First tungsten futures contract could set pricing standards worldwide and influence commodity indices.

Counterpoint

If the futures market fails to attract liquidity, the anticipated price discovery benefits may not materialize, limiting upside for miners.

Key entities

  • CME Group

    Operator of the new tungsten futures contract.

  • Almonty Industries

    Leading tungsten producer highlighted as a beneficiary of the new contract.

Related articles

$CMEHighAI 9/10

CME (CME) Q3 2026 Earnings Call Transcript

CME Group reported Q3 2026 revenue of $1.7B, up 13% YoY, with record market data revenue of $243M. International volume reached 9M contracts/day, up 22% YoY. New products were launched, and cloud migration progress was shared. Adjusted EPS was $3.02, up 13% YoY. The company returned $1B to shareholders. Compute Futures progress depends on CFTC approval.

$RTXHighAI 8/10

Nasdaq and Small Caps Lead Three Day Surge as Crude Slides and Blue Chips Hold Firm

Nasdaq Composite and Russell 2000 led a three-day market rally, with Nasdaq up 2.14% and Russell 2000 up 2.36% for the week. The Dow and S&P 500 also gained over 1.2%. Several companies reported earnings, including RTX (NYSE: RTX), Abbott (NYSE: ABT), CME Group (Nasdaq: CME), M/I Homes (NYSE: MHO), and Lockheed Martin (NYSE: LMT). RTX reported $25.0B in Q3 sales and raised its full-year outlook. Abbott posted 14.5% sales growth. CME Group saw record Q3 revenue.

$CMEHighAI 8/10

CME Group earnings analysis: questions answered and next catalysts

CME Group reported Q3 2026 earnings with revenue of $1.74B and EPS of $3.02, both slightly above estimates. Shares were up 0.27% at $296.12. Volume demand was strong across all asset classes, with international growth notable. The company returned nearly $1B to shareholders. Next catalysts include the launch of CME Securities Clearing and Q4 earnings.

$CMEMed

CME Group Q3 Earnings Call Highlights

CME Group reported average daily margin savings of over $100 billion in Q3, driven by equities and fixed income. Equities savings totaled $47 billion, while fixed income saw record daily savings. International volume rose 22% to 9 million contracts. New products include Single Stock futures and expanded 24/7 trading. CME expects to launch CME Securities Clearing in December and is testing cloud migration. Pricing changes are expected to increase fees by 0.5% to 1%.

$CMEHighAI 9/10

CME Group Q3 Earnings Surpass Estimates, Revenues Rise Y/Y

CME Group reported Q3 2026 adjusted earnings of $3.02 per share, beating estimates by 1.3% and rising 12.7% year over year. Revenue increased 13% to $1.73 billion, driven by higher fees and trading volumes. Operating income rose 17.3% to $1.14 billion. The company had $23.3 billion in cash and $3.4 billion in long-term debt as of Sept. 30, 2026. CME paid $1 billion in dividends and share repurchases during the quarter.

$CMEHighAI 8/10

[CME Group Q3 2026 Earnings Call] CME Posts Record Q3 Revenue of $1.7B, ADV Jumps 16% to 29.4M Contracts as Q4 Tracking 17% Above Record

CME Group reported record Q3 2026 revenue of $1.7B, up 13%, with average daily volume rising 16% to 29.4M contracts. All asset classes saw double-digit growth, and international participation hit a record 9M contracts. The company expects Q4 to be 17% above record levels, driven by strong market demand and product innovation.